Emergent BioSolutions CFO to Retire; Interim Successor Named
CFO Richard S. Lindahl will retire effective Dec. 31, 2026. VP and Treasurer Frank Vargo will become interim CFO on Jan. 1, 2027, and Lindahl will advise through Mar. 31, 2027.
CFO Richard S. Lindahl will retire effective Dec. 31, 2026. VP and Treasurer Frank Vargo will become interim CFO on Jan. 1, 2027, and Lindahl will advise through Mar. 31, 2027.